Drugs / PD-1-M1-NK Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07031011 | Jun 2025 → Jan 2027 expected | cancer | jiuwei cui | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PD-1-M1-NK Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07031011 ↗ |
| Known as | YC-T-001 | “PD-1-M1-NK Cells (YC-T-001)” NCT07031011 ↗ |
| Route | Other | “in the form of intraperitoneal injection” NCT07031011 ↗ |